Mir-135a-3p在无功能垂体腺瘤中的表达及对其侵袭性的影响
Expression of MiR-135a-3p in Non-Functional Pituitary Adenomas and Its Effect on Its Invasiveness
DOI: 10.12677/ACM.2020.108241, PDF,    科研立项经费支持
作者: 谭维康*, 王成浩, 王建鹏, 闫志勇*:青岛大学附属医院神经外科,山东 青岛
关键词: miR-135a-3p无功能垂体腺瘤增殖侵袭性MiR-135a-3p Non-Functional Pituitary Adenomas Proliferation Invasiveness
摘要: 目的:本文探讨miR-135a-3p在无功能垂体腺瘤(NFPA)中的表达及其对NFPA细胞侵袭性的影响。方法:采用实时定量PCR分别检测50例的NFPA组织(侵袭性和非侵袭性各25例);培育正常大鼠垂体瘤细胞株,随机分为实验组和阴性对照组,分别转染miR-135a-3p inhibitor和miR-135a-3p NC,采用实时荧光定量PCR检测miR-135a-3p的表达;转染后分别进行CCK8实验检测垂体瘤细胞增殖能力;Transwell实验检测垂体瘤细胞的迁移能力。结果:结果显示,侵袭性NFPA组中miR-135a-3p表达量明显高于非侵袭性NFPA组(P < 0.05);转染miR-135a-3p inhibitor后垂体瘤细胞株的细胞增殖能力较阴性对照组下降(P < 0.05);miR-135a-3p inhibitor组垂体瘤细胞与阴性对照组相比细胞迁移能力下降(P < 0.05)。结论:miR-135a-3p在NFPA中过表达,其可能调控垂体瘤细胞的增殖从而促进其侵袭行为的发生。
Abstract: Objective: To investigate the expression of miR-135a-3p in nonfunctional pituitary adenoma (NFPA) and its effect on the invasion of NFPA cells. Methods: 50 NFPA tissues (25 invasive and 25 non-invasive) were detected by real-time quantitative PCR. Normal rat pituitary tumor cell lines were cultured and randomly divided into the experimental group and the negative control group. miR-135a-3p inhibitor and miR-135a-3P NC were transfected respectively, and the expression of miR-135a-3P was detected by quantitative real-time PCR. CCK8 assay was used to detect the proliferation of pituitary tumor cells after transfection. Transwell assay was used to detect the migration ability of pituitary tumor cells. Results: The expression level of miR-135a-3p in the invasive NFPA group was significantly higher than that in the non-invasive NFPA group (P < 0.05). After transfection with miR-135a-3p inhibitor, the proliferation ability of pituitary tumor cell lines decreased compared with the negative control group (P < 0.05). Cell migration was decreased in the miR-135a-3p inhibitor group compared with the negative control group (P < 0.05). Conclusion: Overexpression of miR-135a-3p in NFPA may regulate the proliferation of pituitary tumor cells and promote their invasion.
文章引用:谭维康, 王成浩, 王建鹏, 闫志勇. Mir-135a-3p在无功能垂体腺瘤中的表达及对其侵袭性的影响[J]. 临床医学进展, 2020, 10(8): 1610-1616. https://doi.org/10.12677/ACM.2020.108241

参考文献

[1] Ezzat, S., Asa, S.L., Couldwell, W.T., et al. (2004) The Prevalence of Pituitary Adenomas: A Systematic Review. Cancer, 101, 613-619. [Google Scholar] [CrossRef] [PubMed]
[2] Herbert, S.P. and Stainier, D.Y. (2011) Molecular Control of Endothelial Cell Behaviour during Blood Vessel Morphogenesis. Nature Reviews Molecular Cell Biology, 12, 551-564. [Google Scholar] [CrossRef] [PubMed]
[3] Oldfield, E.H. (2014) Editorial: Management of Invasion by Pituitary Adenomas. Journal of Neurosurgery, 121, 501-503. [Google Scholar] [CrossRef
[4] Zhang, Y., Hu, Y., fang, J.Y., et al. (2016) Gain-of-Function miRNA Signature by Mutant p53 Associates with Poor Cancer Outcome. Oncotarget, 7, 11056-11066. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905457/ [Google Scholar] [CrossRef] [PubMed]
[5] Wang, Q.J., Zhang, H.C., Shen, X.J., et al. (2017) Serum microRNA-135a-5p as an Auxiliary Diagnostic Biomarker for Colorectal Cancer. Annals of Clinical Biochemistry, 54, 76-85. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, X., Liu, Y., Gao, J., et al. (2018) Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study. World Neurosurgery, 115, 94-98. [Google Scholar] [CrossRef] [PubMed]
[7] Oldfield, E.H. (2014) Editorial: Management of Invasion by Pituitary Adenomas. Journal of Neurosurgery, 121, 501-503. [Google Scholar] [CrossRef
[8] Ribatti, D., Nico, B. and Crivellato, E. (2009) Morphological and Molecular Aspects of Physiological Vascular Morphogenesis. Angiogenesis, 12, 101-111. [Google Scholar] [CrossRef] [PubMed]
[9] Sorel, O. and Dewals, B.G. (2016) MicroRNAs in Large Herpesvirus DNA Genomes: Recent Advances. BioMolecular Concepts, 7, 229-239. [Google Scholar] [CrossRef] [PubMed]
[10] Ahmad, A., Zhang, W., Wu, M., et al. (2018) Tumor-Suppressive miRNA-135a Inhibits Breast Cancer Cell Proliferation by Targeting ELK1 and ELK3 Oncogenes. Genes Genomics, 40, 243-251. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, L.X., Kang, Z.P., Yang, Z.C., et al. (2018) MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation through Targeting In-Terleukin-17. Cellular Physiology & Biochemistry, 46, 2232-2238. [Google Scholar] [CrossRef] [PubMed]
[12] Zeng, Y.B., Liang, X.H., Zhang, G.X., et al. (2016) miRNA-135a Promotesepatocellular Carcinoma Cell Migration and Invasion by Targeting Forkhead Box O1. Cancer Cell International, 16, 63. [Google Scholar] [CrossRef] [PubMed]
[13] Zhou, W., Li, X., Liu, F., et al. (2012) MiR-135a Promotes Growth and Invasion of Colorectal Cancer via Metastasis Suppressor 1 In Vitro. Acta Biochimica et Biophysica Sinica (Shanghai), 44, 838-846. [Google Scholar] [CrossRef] [PubMed]